光热治疗
纳米载体
药物输送
体内
纳米技术
光热效应
化学
生物物理学
纳米凝胶
靶向给药
阿霉素
材料科学
癌症研究
化疗
医学
生物
外科
生物技术
作者
Liping Zhang,Zaiyu Wang,Rongyuan Zhang,Han Yang,Wenjin Wang,Yun Zhao,Wei He,Zijie Qiu,Dong Wang,Yu Xiong,Zheng Zhao,Ben Zhong Tang
出处
期刊:ACS Nano
[American Chemical Society]
日期:2023-12-13
卷期号:17 (24): 25205-25221
被引量:31
标识
DOI:10.1021/acsnano.3c08409
摘要
Targeted and controllable drug release at lesion sites with the aid of visual navigation in real-time is of great significance for precise theranostics of cancers. Benefiting from the marvelous features (e.g., bright emission and phototheranostic effects in aggregates) of aggregation-induced emission (AIE) materials, constructing AIE-based multifunctional nanocarriers that act as all-arounders to integrate multimodalities for precise theranostics is highly desirable. Here, an intelligent nanoplatform (P-TN-Dox@CM) with homologous targeting, controllable drug release, and in vivo dual-modal imaging for precise chemo-photothermal synergistic therapy is proposed. AIE photothermic agent (TN) and anticancer drug (Dox) are encapsulated in thermo-/pH-responsive nanogels (PNA), and the tumor cell membranes are camouflaged onto the surface of nanogels. Active targeting can be realized through homologous effects derived from source tumor cell membranes, which advantageously elevates the specific drug delivery to tumor sites. After being engulfed into tumor cells, the nanogels exhibit a burst drug release at low pH. The near-infrared (NIR) photoinduced local hyperthermia can activate severe cytotoxicity and further accelerate drug release, thus generating enhanced synergistic chemo-photothermal therapy to thoroughly eradicate tumors. Moreover, P-TN-Dox@CM nanogels could achieve NIR-fluorescence/photothermal dual-modal imaging to monitor the dynamic distribution of therapeutics in real-time. This work highlights the great potential of smart P-TN-Dox@CM nanogels as a versatile nanoplatform to integrate multimodalities for precise chemo-photothermal synergistic therapy in combating cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI